Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Immunic (IMUX) has a market cap of $88.602 million USD. According to our data, Immunic is ranked No.7777 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $88.60 M |
-1.64%
|
| Dec 31, 2024 | $90.08 M |
-33.33%
|
| Dec 29, 2023 | $0.14 B |
7.14%
|
| Dec 30, 2022 | $0.13 B |
-85.37%
|
| Dec 31, 2021 | $0.86 B |
-37.41%
|
| Dec 31, 2020 | $1.38 B |
57.63%
|
| Dec 31, 2019 | $0.87 B |
30.38%
|
| Dec 31, 2018 | $0.67 B |
-96.87%
|
| Dec 29, 2017 | $21.44 B |
36.78%
|
| Dec 30, 2016 | $15.67 B |
-62.24%
|
| Dec 31, 2015 | $41.51 B |
-53.79%
|
| Dec 31, 2014 | $89.83 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
 Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
 Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
 BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
 Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
 Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
 bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
| Market Cap | = | IMUX Stock Price | * | IMUX Shares Outstanding |
| = | $0.98 | * | 90.08 M | |
| = | $88.60 M |